L-carnitine halts apoptosis and myelosuppression induced by carboplatin in rat bone marrow cell cultures (BMC)

Archives of Toxicology

Volumn 79, Issue 7, 2005, Pages 406-413

  Abd Allah, Adel R A ^a   Al Majed, Abdulhakeem A ^a   Al Yahya, Abdulaziz A ^a   Fouda, Soliman I ^a   Al Shabana, Othman A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Antioxidant; Apoptosis; Carboplatin; L carnitine; Myelosuppression

Indexed keywords

CARBOPLATIN; CARNITINE; COLONY STIMULATING FACTOR 1; DNA FRAGMENT; GLUTATHIONE; GRANULOCYTE COLONY STIMULATING FACTOR; MALONALDEHYDE; TRYPAN BLUE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BONE MARROW CELL; BONE MARROW SUPPRESSION; CELL CULTURE; CELL FUNCTION; CELL VIABILITY; COLONY FORMING UNIT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG MECHANISM; GEL ELECTROPHORESIS; HEART PROTECTION; IMMUNOSTIMULATION; INCUBATION TIME; LC 50; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; STEM CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BONE MARROW CELLS; CARBOPLATIN; CARNITINE; CELL SURVIVAL; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; GLUTATHIONE; GRANULOCYTES; MACROPHAGES; MALE; MALONDIALDEHYDE; RATS; RATS, WISTAR;

EID: 22844448533     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-004-0643-3     Document Type: Article

References (45)

1. Alberts DS, Peng YM, Moon TE, Bressler R (1978) Carnitine prevention of adriamycin toxicity in mice. Biomedicine 29(8):265-268
2. Alesci De, Martino Mu Mirani M, Benvenga S, Trimarchi F, Kino T, Chrousos GP (2003) L-carnitine: a nutritional modulator of glucocorticoid receptor functions. FASEB J 17(11):1553-1555
3. Andrieu-Abadie N, Jaffrezou JP, Hatem S, Laurent G, Levade T, Mercaider JJ (1999) L-carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: role of inhibition of ceramide generation. FASEB J 13(12):1501-1510
4. Antman KH (2000) High-dose chemotherapy in breast cancer: the end of the beginning. Biol Blood Marrow Transplant 6:469-475
5. Arafa MM, Sayed-Ahmed M (2003) Protective role of carnitine esters against alcohol-induced gastric lesions in rats. Pharmacol Res 48(3):283-290
6. Arafa HM, Abd-Allah AR, El-Mahdy MA, Ramadan LA, Hamada FM (2003) Immunomodulatory effects of L-carnitine and Q10 in mouse spleen exposed to low-freqency high-intensity magnetic field. Toxicology 187(2-3):171-181
7. Arockia-Rani PJ, Panneerselvam C (2001) Carnitine as a free radical scavenger in aging. Exp Gerontol 36(10): 1713-1726
8. Athanassakis I, Mouratidou M, Sakka P, Evangeliou A, Spilioti M, Vassiliadis S (2001) L-carnitine modifies the humoral immune response in mice after in vitro or in vivo treatment. Int Immunopharmacol 1 (9-10): 1813-1822
9. Atroshi F, Biese I, Saloniemi H, Ali-Vehmas T, Saari S, Rizzo A, Veijalainen P (2000) Significance of apoptosis and its relationship to antioxidants after ochratoxin A administration in mice. J Pharm Pharm Sci 3(3):281-291
10. Burton K (1956) A study of the conditions and mechanism of the diphenylamine reaction for colorimetric estimation of deoxyribonucleic acid. Biochem J 62:315-318
11. Forloni G, Angeretti N, Smiroldo S (1994) Neuroprotective activity of acetyl-L-carnitine: studies in vitro. J Neurosci Res 37(1):92-96
12. Hagen TM, Liu J, Lykkesfeldt T, Wehrt CM, Ingersoll R, Vinarsky V, Bartholomew JC, Ames BN (2002) Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Proc Natl Acad Sci USA 99(4): 1870-1875
13. Hassan MI, Ahmed MI, Kassim SK, Rashad A, Khalifa A (1999) Cis-platinum-induced immunosuppression: relation to melatonin in human peripheral blood mononuclear cells. Clin Biochem 32(8):621-626
14. Huitema ADR, Spaanders M, Mathot RAA, Tibben MM, Holtkamp MJ, Beijnen JH, Rodenhnis S (2002) Relationship between exposure and toxicity in high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin. Ann Oncol 13:374-384
15. Inoue M, Sato EF, Nishikawa M, Park AM, Kira Y, Imada I, Utsumi K (2003) Cross talk of nitric oxide, oxygen radicals, and superoxide dismutase regulates the energy metabolism and cell death and determines the fates of aerobic life. Antioxid Redox Signal 5(4):475-484
16. Kanzawa F, Koizumi F, Kog Y, Nakamura T, Tatasumi Y, Fukomoto H, Saijo N, Yoshioka T, Nishio K (2001) In vitro synergistic interaction between the cisplatin analogue nedaptin and DNA topoisomerase 1 inhibitor irinotecan and the mechanism of this interaction. Clin Cancer Res 7:202-229
17. Karlic H, Lohninger A, Laschan C, Alexander L, Bohmer F, Huemer M, Guthann E, Rapdold E, Pfeilstocher M (2003) Down regulation of carnitine acyltransferase and organic cation transport OCTN2 in mononuclear cells in healthy elderly and patients with myelodysplastic syndrome. J Mol Med 81(7):435-442
18. Kiziltunc A, Cogalgil S, Cerrahoglu L (1998) Carnitine and antioxidants levels in patients with rheumatoid arthritis. Scand J Rheumatol 27(6):441-445
19. Kobayashi K, Kudoh S, Takemoto T, Hino M, Hayashihara K, Nakahiro K, Ando M, Niitani H (1995) In vitro investigation of a combination of two drugs, cisplatin and carboplatin, as a function of the area under the c/t curve. J Cancer Res Clin Oncol 121(12):715-720
20. 53, cytotoxic compounds and cytokines. Proc Natl Acad Sci USA 93:9166-9171
21. Mabro M, Faivre S, Raymond E (1999) A risk-benefit assessment of amifostine in cytoprotection. Drug Saf 21(5):367-387 (Review)
22. Maestroni GJ, Togni M, Covacci V (1997) Norepinephrine protects mice from acute lethal doses of carboplatin. Exp Hematol 25(6):491-494
23. Masse A, Ramirez LH, Bindoula G, Grillon C, Wdzieczak-Bakala J, Raddassi J, Deschamps de Paillette E, Mencia-Huerta JM, Koscielny S, Potier P, Sainteny F, Carde P (1998) The tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (Goralatide) protects from doxorubicin-induced toxicity: improvement in mice survival and protection of bone marrow stem cells and progenitors. Blood 91(2):411-419
24. Miguez MP, Soler F, Garcia-Rubio G (1998) Accentuation of paraquat-induced toxicity by L-carnitine in mice. Biofactors 8(1+2):73-78
25. Mosca L, Marcellini S, Perluigi M, Mastroiacovo P, Moretti S, Famularo G, Peluso I, Santini G, De Simone C (2002) Modulation of apoptosis and improved redox metabolism with the use of a new antioxidant formula. Biochem Pharmacol 63(7):1305-1314
26. Moskowitz CH, Bertino JR, Glassman JR, Hedrick EE, Munte S, Goady-Lyons N, Agus DB, Goy A, Jurcic J, Noy A, Q Brien J, Portlock C, Straus DS, Childs B, Frank R, Yahalom J, Filippa D, Louie D, Nimer SD, Zelenetz AD (1999) Ifosfamide, carboplatin and etopside: a highly effective cytoreduction and peripheral blood progenitor-cells mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma. J Clin Oncol 17(12):3776-3785
27. Ohkawa H, Ohish N, Yagi K (1979) Assay for lipid peroxides in animal issue by thiobarbituric acid. Anal Biochem 95:351-358
28. Pathak AR, Singh N, Khanna N, Reddy VG, Prasad KN, Kochupillai V (2002) Potential of the effect of paclitaxel and carboplatin by antioxidant mixture on human cancer H520 cells. J Am Coll Nutr 21(5):416-421
29. Perandones CE, Illera AV, Peckham D, Stunz LL, Ashman RF (1993) Regulation of apoptosis in vitro in mature murine spleen T-cells. J Immunol 151(7):3521-3529
30. Prajda N, Kralovanszky J, Gal F, Kiss F, Kerpel-Fronius S (1989) Evaluation of side effects of platinum complexes (CDDP, CBDCA, CHIP) on rat bone marrow. In Vivo 3(4):267-270
31. Ramadan LA, Abd-Allah AR, Aly HA, Saad-el-Din AA (2002) Tisticular toxicity effects of magnetic field exposure and prophylactic role of coenzyme Q10 and L-carnitine in mice. Pharmacol Res 46(4):363-370
32. Rinehart J, Keville L, Measel J, Spiekerman AM, Burke K (1995) Corticosteroid alteration of carboplatin-induced hematopoietic toxicity in a murine model. Blood 86(12):4493-4499
33. Sadler PJ, Guo Z (1998) Metal complex in medicine: design and mechanism of action. Pure Appl Chem 70(4):863-871
34. Sayed-Ahmed MM, Shaarawy S, Shouman SA, Osman AM (1999) Reversal of doxorubicin-induced cardiac metabolic damage by L-carnitine. Pharmacol Res 39(4):298-295
35. Schroyens WA, Meeker JB, Dodion P, Stryckmans PA, Rozencweig M (1988) Comparative effect of cisplatin, spiroplatin, carboplatin, iproplatin and JM40 in a human myeloid clonogenic assay. Eur J Cancer Clin Oncol 24(8):1309-1312
36. She-Ning QI, Yashida A, Wang Z, Ueda T (2004) GP7 can induce apoptosis DNA fragmentation of Human leukemia cells through caspase-3-dependent and -independent pathways. Int J Med 13:163-167
37. Silber R, Farber MC, Papdopaulos E (1992) Glutathione depletion in chronic lymphocytic leukemia B lymphocytes. Blood 80(8):2038-2043
38. Stuart MJ, Chao NS, Horning SJ, Wong RM, Negrin RS, Jobnston LJ, Sbizuru JA, Long GD, Blume KG, Stockerl-Goldstein KE (2001) Efficacy and toxicity of a CCNU-containing high dose chemotherapy regimen followed by autologous hemopoietic cell transplantion in relapsed or refractory Hodgkin's disease. Biol Blood Marrow Transplant 7:552-560
39. Su WC, Chang SL, Chen TY, Chen JS, Tsao CJ (2000) Comparison of in vitro growth-inhibitory activity of carboplatin and cisplatin on leukemic cells and hematopoietic progenitors: the myelosuppressive activity of carboplatin may be greater than its antileukemic effect. Jpn J Clin Oncol 30(12):562-567
40. Treskes M, Boven E, van de Loosdrecht AA, Wijffels JF, Cloos J, Peters GJ, Pinedo HM, van der Vijgh WJ (1994) Effects of the modulating agent WR2721 on myelotoxicity and antitumour activity in carboplatin-treated mice. Eur J Cancer 30A(2):183-187
41. Vescovo G, Ravara B, Gobbo V, Sandri M, Angelin A, Barbera MD, Dona M, Peluso G, Calvani M, Mosconi L, Libera LD (2002) L-carnitine: a potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure. Am J Physiol Cell Physiol 283:C802-C810
42. Winterbourn CC (2002) Biological reactivity and biomarkers of neutrophil oxidant, hypochlorous acid. Toxicology 181-182:223-227
43. Wolfang GH, Dominick MA, Walsh KM, Hoeschele JD, Pegg DG (1994) Comparative nephrotoxicity of a novel platinum compounds, cisplatin, carboplatin in male wistar rats. Fundam Appl Toxicol 22(1):73-79
44. Yang Z, Faustino PK, Andrews CD, Monastra R, Rasmassen AA, Ellison CD, Cullen KJ (2000) Decreased cisplatinum DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell line. Cancer Chemother Pharmacol 46(4):255-262
45. Zisowsky J, Becker A, Weykam S, Kassack M, Jaehde U (2003) Assessment of platinum sensitivity in human tumor cells. Int J Clin Pharmacol Ther 41(12):612-613